BIAGIOLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 1.690
EU - Europa 1.021
AS - Asia 401
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.118
Nazione #
US - Stati Uniti d'America 1.688
IT - Italia 364
IE - Irlanda 352
HK - Hong Kong 182
VN - Vietnam 96
CN - Cina 82
DE - Germania 40
RU - Federazione Russa 40
SE - Svezia 39
FI - Finlandia 37
FR - Francia 36
UA - Ucraina 32
GB - Regno Unito 21
BE - Belgio 18
SG - Singapore 18
AT - Austria 11
CH - Svizzera 11
TR - Turchia 9
NL - Olanda 8
LB - Libano 5
UZ - Uzbekistan 5
AL - Albania 2
CA - Canada 2
CI - Costa d'Avorio 2
EU - Europa 2
GR - Grecia 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AU - Australia 1
BG - Bulgaria 1
EE - Estonia 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
TW - Taiwan 1
Totale 3.118
Città #
Chandler 501
Dublin 348
San Mateo 196
Hong Kong 182
Perugia 155
Dong Ket 96
Ann Arbor 85
Medford 76
Princeton 75
Altamura 63
Lawrence 52
Wilmington 51
Dearborn 41
Andover 37
Beijing 37
Redmond 23
Redwood City 18
Brussels 17
Ashburn 16
Norwalk 16
Saint Petersburg 16
Singapore 13
Houston 12
Los Angeles 12
Den Haag 8
Cambridge 7
Chicago 7
Florence 7
Lappeenranta 7
Vienna 7
Des Moines 6
Helsinki 6
Izmir 6
San Paolo di Civitate 6
Woodbridge 6
San Diego 5
Terni 5
Jacksonville 4
Menlo Park 4
New York 4
Rome 4
Bologna 3
Falls Church 3
Lausanne 3
Lugano 3
Shanghai 3
Abidjan 2
Acireale 2
Arzano 2
Boardman 2
Bratislava 2
Chengdu 2
Esslingen am Neckar 2
Frankfurt Am Main 2
Fremont 2
Hanover 2
Hefei 2
London 2
Moscow 2
Naples 2
Philadelphia 2
Poggio Mirteto 2
Radeberg 2
Rocca Di Papa 2
Stroncone 2
Toronto 2
Wayne 2
Zero Branco 2
Ankara 1
Avignon 1
Baotou 1
Bastia umbra 1
Beirut 1
Boydton 1
Castiglione del Lago 1
Cava Dei Tirreni 1
Conegliano 1
Cormeilles-en-Parisis 1
Deruta 1
Fairfield 1
Foligno 1
Frankfurt am Main 1
Guangzhou 1
Halle 1
Harbin 1
Iglesias 1
Jinan 1
Kaohsiung 1
Kiev 1
Kocaeli 1
Kraków 1
Landshut 1
Leawood 1
Lexington 1
Lit 1
Magdeburg 1
Marseille 1
Melbourne 1
Metuchen 1
Nanjing 1
Totale 2.328
Nome #
Wnt/beta-Catenin Signaling Induces Integrin alpha 4 beta 1 in T Cells and Promotes a Progressive Neuroinflammatory Disease in Mice 84
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 76
GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling 74
LACK OF GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) RESULTS IN B CELL LYMPHOPROLIFERATIVE DISORDER IN MICE 71
Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice 71
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 70
Glucocorticoid-induced leucine Zipper (GILZ) controls T lymphocytes differentation 69
GILZ REGULATES PRODUCTION OF PTREG AND TTREG CELLS AND IS NECESSARY FOR GLUCOCORTICOID-MEDIATED INDUCTION OF TREG CELLS 66
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 66
Role of GILZ in mediating the anti-inflammatory actions of glucocorticoids 57
Long-glucocorticoid-induced leucine zipper (L-GILZ) expression as a new diagnostic biomarker for male infertility associated with exposure to electromagnetic fields and radiofrequency radiation. 56
Glucocorticoid and B cell development: role of Glucocorticoid-induced leucine zipper 54
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 54
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 54
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 53
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 53
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 51
Glucocorticoid indeced lLeucine Zipper protein (GILZ) regulates Hematopoietic stem cell engrafment and myeloid differentiation in a mouse model of CEBPA mutant acute myeloid leukemia 50
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 50
Glucocorticoid-induced leucine Zipper (GILZ) anf the new isoform L-GILZ mediates the anti-inflammatory effects of glucocorticoids 48
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 48
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 48
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 47
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 47
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 47
The effect of Ara-C treatment on hematopoietic stem cell expasion and leukemogenesis in a mouse model of CEBPA mutant acute myeloid leukemia 46
Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment 45
Long- Glucocrticoid induced Leucine Zipper interacts with Ras pathway and is essential for spermatogenesis 44
Recombinant long-Glucocorticoid-induced leucine zipper (L-GILZ) protein restores the control of proliferation in gilz KO spermatogonia 44
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 44
GILZ regulates the development of Treg cells via regulation of crosstalk between Glucocorticoids and TGF-beta 43
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 42
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 42
Bile Acids Activated Receptors Regulate innate immunity 41
REGULATION OF HEMATOPOIETIC STEM CELL (HSC) DEVELOPMENT: ROLE OF GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) 40
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 40
Glucocorticoid-induced leucine zipper (GILZ) is a regulator of intestina immune homeostatsis and anti-inflammatory effects of glucocorticoids 38
Sa1931 – Physico-Chemistry, Proteomics and In Vivo Comparative Tests to Reveal Variability in Multistrain Probiotic Formulations 38
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 38
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 37
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 37
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 37
Immunomodulatory functions of FXR 37
Glucocorticoid-induced leucine zipper (GILZ) is involved in Th2-mediated oxazolone-induced colitis 36
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 36
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 36
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 36
Bile acids and their receptors in metabolic disorders 35
Bile Acids Activated Receptors in Inflammatory Bowel Disease 35
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 34
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 34
Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH) 34
The identification of farnesoid X receptor modulators as treatment options for non-alcoholic fatty liver disease 34
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 33
Glucocorticoid-Induced Leucine Zipper (GILZ) controls inflammation and tissue damage after spinal cord injury. 32
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 32
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 32
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 32
Bile Acid Signaling in Inflammatory Bowel Diseases 32
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 32
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 31
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 31
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 31
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease 30
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 28
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 28
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 26
Special FX: Harnessing the Farnesoid-X-Receptor to Control Bile Acid Synthesis 26
Future trends in the treatment of non-alcoholic steatohepatitis 25
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity 25
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 24
Navigation in bile acid chemical space: Discovery of novel FXR and GPBAR1 ligands 23
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 23
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 22
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 21
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 20
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 19
Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases 19
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 18
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 17
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 17
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 14
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 13
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 8
Bile acids and bile acid activated receptors in the treatment of Covid-19 6
Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists 6
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 6
Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders 5
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 5
Totale 3.339
Categoria #
all - tutte 14.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 18 1
2019/2020197 12 9 9 3 13 34 19 7 15 47 18 11
2020/2021402 11 16 7 14 125 22 23 18 17 26 17 106
2021/2022673 13 143 7 16 14 6 38 175 15 69 88 89
2022/20231.378 90 242 14 124 132 123 2 82 495 3 55 16
2023/2024401 31 48 20 17 22 3 141 31 31 20 37 0
Totale 3.339